Link: Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference
Link: Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference
Read this article: Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow
Read the original here: Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting
Link: Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
See original here: Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
More: Alvotech Provides Regulatory Update on AVT02 Biologics License Application
View post: Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological...
See the rest here: Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023
Go here to read the rest: Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China
Go here to read the rest: Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
Recent Comments